Background: Hereditary transthyretin amyloidosis (ATTRv) has a heterogeneous clinical presentation, and the symptoms are mainly neuropathic, including autonomic, sensory, and motor impairment. In addition, it may be associated with gastrointestinal, cardiac, renal, and ocular involvement. Diagnosis in the early stages is essential to allow appropriate treatment and to prevent or slow the progression of the disease. Objective: Early detection of the disease in asymptomatic ATTRv carriers. Methods: A cross-sectional study of asymptomatic individuals with ATTRv was conducted at the neuromuscular diseases outpatient clinic of Hospital Pedro Ernesto in Rio de Janeiro from April 2019 to November 2023. Results: 4 out of 16 individuals (25%) were diagnosed with the disease through salivary gland biopsy, after presenting alterations in at least two complementary tests related to the evaluation of small-fiber neuropathy, even if those individuals remained completely asymptomatic. Conclusion: Small-fiber neuropathy was the earliest sign of disease onset, occurring in all four individuals diagnosed and the tests that proved to be more sensitive were sympathetic skin response (SSR) and quantative sensory testing (QST)
Andrade et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: